A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
Clinical trial NCT04777331 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04777331
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2024-09-11
- Enrollment
- 586
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.